Testing for genetic risk factors may improve myeloma treatments by identifying those at risk for more aggressive disease. This study, published in the Journal of Clinicial Oncology and led by researchers in London, including our own Myeloma Institute Director, Dr. Gareth Morgan, is the first to link genetic mutations in myeloma cells to the chances of surviving the disease.
Genetic Mutation Analysis May Improve Treatment in Multiple Myeloma
- 15 hours ago
We're going the distance in the fight against multiple myeloma and related diseases. Dr. Gareth Morgan and the... fb.me/8HqXLzq7H15 hours ago